Lithuania vs Tonga: Prevalence of current tobacco use
Prevalence of current tobacco use over time
- Lithuania
- Tonga
How they compare
Tonga currently reports 32.1% against 31.4% in Lithuania, a difference of 0.7%.
The two have swapped places 1 time across 9 shared years of data; in 2000 it was Lithuania ahead.
Lithuania ranks 24th and Tonga ranks 22nd of 166 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 41.1% | 32.8% | 8.4% | Lithuania |
| 2010s | 36.5% | 32.4% | 4.1% | Lithuania |
| 2020s | 32.1% | 32.1% | 0.0% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of current tobacco use, Lithuania or Tonga?
- Tonga, at 32.1% against 31.4% in Lithuania as of 2024.
- What is the difference in prevalence of current tobacco use between Lithuania and Tonga?
- 0.7%, with Tonga ahead.
- How many years of comparable data are there for Lithuania and Tonga?
- 9 years are reported by both, from 2000 to 2024.
- How do Lithuania and Tonga rank globally for prevalence of current tobacco use?
- Lithuania ranks 24th and Tonga ranks 22nd of 166 countries.
- Where does this data come from?
- Global Health Observatory Data Repository, World Health Organization (WHO), published as Prevalence of current tobacco use (% of adults). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.